These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
257 related articles for article (PubMed ID: 3965285)
1. The Kellersberger memorial lecture, 1984. Chemotherapy of leprosy--a tool for leprosy control. Levy L Ethiop Med J; 1985 Jan; 23(1):31-42. PubMed ID: 3965285 [No Abstract] [Full Text] [Related]
2. Leprosy at a turning point? Harboe M Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):312-8. PubMed ID: 11221095 [No Abstract] [Full Text] [Related]
3. Kellersberger memorial lecture, 1988. Technology for leprosy control--progress and prospects. Noordeen SK Ethiop Med J; 1989 Jul; 27(3):161-80. PubMed ID: 2666127 [No Abstract] [Full Text] [Related]
4. Multi-drug therapy in leprosy: an effective method of control. Indian J Lepr; 1984; 56(1):102-12. PubMed ID: 6548238 [TBL] [Abstract][Full Text] [Related]
5. Six months MDT for paucibacillary leprosy: nerve damage and relapse. Wheate HW Lepr Rev; 1986 Jun; 57(2):179. PubMed ID: 3747708 [No Abstract] [Full Text] [Related]
6. Multidrug therapy regimen for leprosy. Firooz A J Am Acad Dermatol; 2006 Dec; 55(6):1115; author reply 1115. PubMed ID: 17110233 [No Abstract] [Full Text] [Related]
8. Multidrug therapy in the control of leprosy. A field study. Becx-Bleumink M Trop Geogr Med; 1994; 46(2):109-14. PubMed ID: 8079385 [No Abstract] [Full Text] [Related]
9. Report of combined therapy in leprosy with rifampicin and isoprodian conducted at the Bisidimo-center, Ethiopia. Rohde R Lepr Rev; 1975 Jun; 46(2 Suppl):199-205. PubMed ID: 1100961 [No Abstract] [Full Text] [Related]
10. Twenty five years follow up of MB leprosy patients retreated with a modified MDT regimen after a full course of dapsone mono-therapy. Jing Z; Zhang R; Zhou D; Chen J Lepr Rev; 2009 Jun; 80(2):170-6. PubMed ID: 19743621 [TBL] [Abstract][Full Text] [Related]
11. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy. Li HY; Ran SP; Weng XM; Li TG; Deng XH; Li FT Indian J Lepr; 2001; 73(1):1-10. PubMed ID: 11326592 [TBL] [Abstract][Full Text] [Related]
12. Polytherapy in multibacillary leprosy patients in Nepal. Samuel NM; Samual S; Fairbairn T; Adiga RB Singapore Med J; 1985 Apr; 26(2):203-6. PubMed ID: 4035403 [No Abstract] [Full Text] [Related]
13. Treatment of Hansen's disease. Alto WA Am Fam Physician; 2002 Apr; 65(7):1280, 1282; author reply 1282. PubMed ID: 11996412 [No Abstract] [Full Text] [Related]
14. Rationale of the multidrug regimens recommended by a World Health Organization Study Group on Chemotherapy of Leprosy for Control Programs. Ellard GA Int J Lepr Other Mycobact Dis; 1984 Sep; 52(3):395-401. PubMed ID: 6541207 [No Abstract] [Full Text] [Related]
15. [New WHO recommendations for the treatment of leprosy]. Acta Leprol; 1997; 10(4):189. PubMed ID: 9527754 [No Abstract] [Full Text] [Related]
16. Chemotherapy of leprosy for control programmes. World Health Organ Tech Rep Ser; 1982; 675():1-33. PubMed ID: 6806990 [No Abstract] [Full Text] [Related]
17. Short term WHO advised multiple drug treatment of paucibacillary patients. Naafs B; Lyons NF; Matemera BO; Ellis BP Indian J Lepr; 1986; 58(2):348-53. PubMed ID: 3805802 [No Abstract] [Full Text] [Related]
18. A computer simulation of the effect of multidrug therapy on the incidence of leprosy. Lechat MF; Misson CB; Vanderveken M; Vellut CM; Declercq EE Ann Soc Belg Med Trop; 1987 Mar; 67(1):59-65. PubMed ID: 3632078 [No Abstract] [Full Text] [Related]
19. A overview of ocular leprosy after 2 decades of multidrug therapy. Lewallen S; Courtright P Int Ophthalmol Clin; 2007; 47(3):87-101. PubMed ID: 17667278 [No Abstract] [Full Text] [Related]
20. Dapsone drug resistance in the MDT era. Roche PW; Neupane KD; Failbus SS; Butlin CR Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097 [No Abstract] [Full Text] [Related] [Next] [New Search]